drug · small molecule
vatiquinone
Phase 3updated 3mo agoby $PTC PTC INC.🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 10 investigational indications.
targets
NAD(P)H dehydrogenase [quinone] 1
all catalysts(0)
nothing on the calendar yet
Trials studying vatiquinone
- phase3A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia
- —Vatiquinone Expanded Access Protocol
- phase3A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy
- phase3A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease
- phase3A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia
- phase2A Study of Vatiquinone for the Treatment of Participants With Friedreich Ataxia
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 40m ago
Found something off?
comments(0)
5-min edit window · permanent after that